SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Merck
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1580 80 0 MRK
Emcee:  Alfred W. Post Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1455Tysabri's history is that it was wrongly associated with the deaths of two pRampex-1/26/2006
1454I am not sure you understand what conditions Tysabri would be approved, if it ismopgcw-1/26/2006
1453Perhaps after Tysabri is approved, Merck will buy Elan and dominate the multipleRampex-1/26/2006
1452Message 22099897mopgcw-1/26/2006
1451gs: MRK (U/N): Downgrading to Underperform from In-Line 52-Week Range US$35-26 mopgcw-1/6/2006
1450gs: European Pharma: Lipitor patent win; sector implications Late Friday, Decemmopgcw-12/19/2005
1449gs: MRK(IL/N): Guidance to drive organization, execution will drive the shares mopgcw-12/19/2005
1448Merck Plans More Cost-Cutting By THE ASSOCIATED PRESS Published: December 16, Doc Bones-12/16/2005
1447Merck Vaccine for Rotavirus Is Backed by an FDA Panel By JENNIFER CORBETT DOOREDoc Bones-12/15/2005
1446<b>MorphoSys, Merck In Licensing Agreement</b> news.morningstar.comcdtejuan-12/14/2005
1445>>>>>>>>>>> There are three vaccine products inJohn McCarthy-12/14/2005
1444Merck seeks shot in its profit arm Vaccines could help ease fiscal pain from VioJohn McCarthy-12/14/2005
1443Citigroup: MRK: Restructuring Program Encouraging, But Is It Enough? November mopgcw-12/11/2005
1442Citigroup: MRK: More Negative Vioxx Headlines... December 8, 2005 HOLD (mopgcw-12/11/2005
1441Merck to Unveil Restructuring Plan Drug Giant to Reduce Jobs And Plants, NarrowDoc Bones-11/27/2005
1440Merck Antiretroviral Drug Reduced HIV in Clinical Trial DOW JONES NEWSWIRES NovDoc Bones-11/21/2005
1439Vioxx Judge Wants Long-Use Cases Next By BARBARA MARTINEZ Staff Reporter of THmopgcw-11/11/2005
1438Merck Faces A Crossroads In Vioxx Cases By BARBARA MARTINEZ Staff Reporter of mopgcw-11/7/2005
1437mealeys.comsammy™ -_--11/5/2005
1436Citi MRK: Vioxx Win in NJ; Two Down, Several Thousand To Go... mopgcw-11/5/2005
1435Message 21853865mopgcw-11/3/2005
1434Merck Scores Major Victory In the Second Vioxx Trial... By HEATHER WON TESORIERWilliam F. Wager, Jr.-11/3/2005
1433Message 21836025mopgcw-11/1/2005
1432citi: Merck & Co., Inc. Citigroup Investment Research October 24, 2005 mopgcw-11/1/2005
1431Merck Announces Third-Quarter 2005 Earnings Per Share (EPS) of 65 Cents Monday Omopgcw-10/24/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News